Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Vanda Pharmaceuticals (VNDA) Cost of Revenue (2016 - 2025)

Vanda Pharmaceuticals' Cost of Revenue history spans 13 years, with the latest figure at $3.8 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 47.99% to $3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.0 million, a 15.29% increase, with the full-year FY2025 number at $13.0 million, up 15.29% from a year prior.
  • Cost of Revenue hit $3.8 million in Q4 2025 for Vanda Pharmaceuticals, up from $3.0 million in the prior quarter.
  • Over the last five years, Cost of Revenue for VNDA hit a ceiling of $6.8 million in Q3 2021 and a floor of $2.6 million in Q3 2024.
  • Historically, Cost of Revenue has averaged $4.5 million across 5 years, with a median of $3.7 million in 2025.
  • Biggest five-year swings in Cost of Revenue: plummeted 51.53% in 2023 and later skyrocketed 47.99% in 2025.
  • Tracing VNDA's Cost of Revenue over 5 years: stood at $6.2 million in 2021, then grew by 0.03% to $6.2 million in 2022, then crashed by 44.53% to $3.5 million in 2023, then dropped by 25.14% to $2.6 million in 2024, then skyrocketed by 47.99% to $3.8 million in 2025.
  • Business Quant data shows Cost of Revenue for VNDA at $3.8 million in Q4 2025, $3.0 million in Q3 2025, and $2.7 million in Q2 2025.